Avsar.

Healthcare · Hospital

Fortis Healthcare Ltd (FORTIS)

₹768.15

Mkt cap
₹57,992 Cr
P/E ratio
54.40
P/B
5.86
Div yield
0.13%
ROE
11.20%
ROCE
13.40%
EPS (TTM)
₹14.12
Book value
₹131
52W range
705–1,068
Sector
Healthcare

Price history

Previous close

FHL was incorporated in February 1996. The company’s first healthcare facility became operational in Mohali, Punjab in 2001. It is a leading integrated healthcare service provider in India. The healthcare verticals of the company primarily comprise hospitals, diagnostics and day care specialty facilities. Currently, the company operates its healthcare delivery services in India, Nepal, Dubai and Sri Lanka with 36 healthcare facilities with approximately 4,000 operational beds. [1] Company controls its diagnostics business through its 57% owned subsidiary SRL Limited. It is amongst the largest private diagnostics chains. It has a presence in over 600 cities and towns, with an established strength of 415 laboratories, 8,200 direct clients and 1,400 Collection Centers. [2]

NSE FORTISBSE 532843
Health check
Cautious
ValuationFair
ProfitabilityAverage
GrowthModerate
TechnicalsBearish
52-week range
−28.06% from high
₹768
₹705+8.97% from low₹1,068
Current
₹768.15
Prev close
₹754.90
Day
+1.76%
Price performance
1D
+1.76%
1W
+7.75%
1M
−6.55%
3M
−19.04%
6M
−17.86%
1Y
−26.80%
YTD
−16.03%

Financials

Revenue, profit & margin
P/E ratio
54.4×
FORTIS is 23% above the sector median of 44.4×
FORTIS54.4×
Sector median44.4×
 Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Trend
Sales1,6571,7701,6801,7861,8591,9881,9282,0072,1672,3312,2652,3652,545
Expenses1,3861,4401,3961,4051,5161,5541,5531,5721,6761,7751,7591,8322,008
Operating Profit272330284381343435375435491556506532537
OPM %16%19%17%21%18%22%19%22%23%24%22%23%21%
Other Income1018191714-4247-293150-34-228
Interest31323335353645687075868480
Depreciation79848792919597102101106120122122
Profit before tax171233183271230261279237351425266324363
Tax %27%21%27%25%24%26%9%21%24%23%26%16%25%
Net Profit124184134203174193254188267329197271273
EPS in Rs1.482.301.782.372.202.343.282.443.454.262.573.523.53
Raw PDF

Earnings

Results dates & reactions
Next results
5 Nov '26scheduled

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

Avg earnings-day move +0.22% · closed higher next day 26 of last 60
 Q2FY24Q3FY24Q4FY24Q1FY25Q2FY25Q3FY25Q4FY25Q1FY26Q2FY26Q3FY26Q4FY26Q1FY27
Broadcast10 Nov '23◦7 Feb '24◦23 May '24◦6 Aug '24◦8 Nov '24◦7 Feb '25◦20 May '25◦6 Aug '25◦11 Nov '25◦13 Feb '26◦22 May '26◦6 Aug '26◦
Earnings day+2.59%−2.54%−1.48%−2.14%+0.52%−3.55%−1.05%+3.01%−1.77%−0.11%+1.04%+3.82%
+1 day−0.08%−3.86%−2.99%−1.56%+3.62%−5.34%+6.57%+4.57%−3.43%−1.05%+0.65%+2.73%
+5 days+3.62%−4.29%+1.31%+5.08%+5.97%−5.64%+4.63%+8.61%−6.48%+0.32%−3.23%+0.98%
+15 days+7.39%−9.81%+7.10%+8.43%+14.52%−1.70%+12.53%+7.75%−8.98%−3.81%+0.91%+0.73%
+30 days+12.77%−10.54%−2.77%+18.84%+8.29%−0.68%+16.70%+12.60%−8.53%−13.96%−1.73%−2.88%
FilingXBRLXBRLXBRLXBRLXBRLXBRLXBRLXBRLXBRLXBRLXBRLXBRL

Corporate actions

Last 6 months
KindValueEx-dateRecord
dividend
Dividend - Re 1 Per Share
—24 Jul '2624 Jul '26

Results analysis

Shareholding

as of Sep 2026
31.17%Promoter
Promoters31.17%
FIIs23.20%2.00
DIIs34.45%2.22
Public11.18%0.22
Ownership trend

Peers

7 companies
Valuation vs quality
P/E × ROCE · bubble = market cap
NameCMPP/EMkt CapDiv YldNP QtrQtr Profit VarSales QtrQtr Sales VarROCE
Apollo Hospitals₹8,448.0057.741,21,4690.24%610+34.17%7,044+20.56%17.45%
Manipal Health₹669.1599.4188,0180.00%243−7.86%3,091+38.12%12.10%
Max Healthcare₹860.0058.9383,7050.23%414−15.54%2,569+20.31%14.71%
Aster DM Quality₹681.15164.5059,3740.44%29−46.12%1,311+21.60%11.57%
Fortis Health.₹768.1554.3657,9920.13%273+3.39%2,545+17.46%13.45%
Narayana Hrudaya₹1,720.2038.8535,1540.26%301+16.61%2,844+73.01%15.50%
Global Health₹1,270.3059.6634,1560.04%157−0.18%1,304+26.50%17.37%
Median: 31 Co.₹509.2044.386,3630.00%30+17.80%403+22.28%14.62%

Filings

Annual reports15
Annual Report 2026Annual Report 2025Annual Report 2024Annual Report 2023Annual Report 2022Annual Report 2021Annual Report 2020Annual Report 2019Annual Report 2018Annual Report 2017Annual Report 2016Annual Report 2015Annual Report 2014Annual Report 2013Annual Report 2013
Concall transcripts62
TranscriptSep 2026RECSep 2026TranscriptAug 2026PPTAug 2026RECAug 2026TranscriptMay 2026PPTMay 2026TranscriptFeb 2026PPTFeb 2026RECFeb 2026PPTJan 2026TranscriptNov 2025PPTNov 2025RECNov 2025TranscriptAug 2025PPTAug 2025TranscriptMay 2025PPTMay 2025TranscriptFeb 2025TranscriptFeb 2025PPTFeb 2025RECFeb 2025TranscriptNov 2024PPTNov 2024
Credit ratings6
Rating update 9 SepcrisilRating update 5 JancrisilRating update 1 Sep 2025crisilRating update 30 Sep 2024crisilRating update 3 Apr 2024crisilRating update 27 Feb 2024crisil
Announcements5
Resignation Of A Senior Management Personnel 31 Oct - Dr. Ritu Garg resigned as Chief Growth & Innovation Officer, effective October 31, 2026.Announcement under Regulation 30 (LODR)-Change in Management 31 Oct - Dr. Ritu Garg resigns as Chief Growth & Innovation Officer, effective October 31, 2026.Resignation Of A Senior Management Personnel 31 Oct - Dr. Ritu Garg resigned as Chief Growth & Innovation Officer effective October 31, 2026.Announcement under Regulation 30 (LODR)-Change in Management 31 Oct - Dr. Ritu Garg resigned as Chief Growth & Innovation Officer effective October 31, 2026.Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 29 Oct